Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all‐cause mortality in hemodialysis patients: A prospective cohort study

Publisher： John Wiley & Sons Inc

E-ISSN： 1542-4758|22|1|82-92

ISSN： 1492-7535

Source： Hemodialysis International, Vol.22, Iss.1, 2018-01, pp. : 82-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose tocopherol increases all-cause mortality

By  

Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Aspirin reduces all-cause mortality in CAD

By  

Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

New evidence supports the use of implantable cardioverter defibrillators (ICDs) to reduce all-cause mortality among primary prevention patients.

By  

Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality

By Psutka Sarah P.   Carrasco Alonso   Schmit Grant D.   Moynagh Michael R.   Boorjian Stephen A.   Frank Igor   Stewart Suzanne B.   Thapa Prabin   Tarrell Robert F.   Cheville John C.   Tollefson Matthew K.  

Cancer, Vol. 120, Iss. 18, 2014-09 ,pp. : 2910-2918

Blackwell Publishing

Access to resources Recommend Favorite

Digoxin and mortality in atrial fibrillation: a prospective cohort study

By Hallberg Pär   Lindbäck Johan   Lindahl Bertil   Stenestrand Ulf   Melhus Håkan  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 959-971

Springer Publishing Company

Access to resources Recommend Favorite